Morphologic blood pattern in patients treated with Ledakrin.
D000166:Acridines / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001773:Blood Cells / Q000187:drug effects*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy; D007958:Leukocyte Count; D008214:Lymphocytes; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009564:Nitracrine / Q000494:pharmacology* / Q000627:therapeutic use
D000166:Acridines; D000970:Antineoplastic Agents; D009564:Nitracrine